Metis Global Partners, LLC Kamada LTD Transaction History
Metis Global Partners, LLC
- $2.71 Billion
- Q1 2024
A detailed history of Metis Global Partners, LLC transactions in Kamada LTD stock. As of the latest transaction made, Metis Global Partners, LLC holds 20,856 shares of KMDA stock, worth $118,253. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,856
Previous 33,001
36.8%
Holding current value
$118,253
Previous $201,000
41.79%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding KMDA
# of Institutions
33Shares Held
5.67MCall Options Held
300Put Options Held
151K-
Phoenix Holdings Ltd. Givatayim, L31.92MShares$10.9 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.33MShares$7.51 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny847KShares$4.8 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA625KShares$3.54 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA441KShares$2.5 Million0.01% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $254M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...